Day: March 2, 2026

Colliers acquires Rome’s leading residential asset advisor

Written by Customer Service on March 2, 2026. Posted in Mergers And Acquisitions.

Enhances capabilities in development and urban regeneration projectsColliers acquires Progedil, Rome’s leading residential asset advisorColliers acquires Progedil, expanding Colliers’ ability to advise on large-scale urban regeneration and new-build development projects.ROME, March 02, 2026 (GLOBE NEWSWIRE) — Global diversified professional services and investment management company Colliers announces the acquisition of Progedil, expanding Colliers’ ability to advise on large-scale urban regeneration and new-build development projects in one of Italy’s most dynamic residential markets. As part of the transaction, Progedil’s senior leadership team has retained significant equity in the business and will continue to lead the day-to-day operations. Progedil provides full-service project marketing for residential...

BioSyent Announces Closing of the Acquisition of Oral Science Inc.

Written by Customer Service on March 2, 2026. Posted in Mergers And Acquisitions.

MISSISSAUGA, Ontario, March 02, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture (TSXV): RX) is pleased to announce that it has successfully closed the previously-announced acquisition of Oral Science Inc. (“Oral Science”), a privately-owned Canadian distributor of specialized healthcare products for dental hygiene and oral health based in Brossard, Quebec. Pursuant to the terms of a Share Purchase Agreement (“SPA”) dated February 8, 2026, BioSyent, through its wholly-owned subsidiary, completed the acquisition of Oral Science from the shareholders of Oral Science (the “Sellers”) in an arm’s length transaction. The aggregate purchase price was $25.5 million, satisfied by: (i) a cash payment of $22.5 million to the Sellers of which $0.2 million will be satisfied with the grant of 12,666 Restricted Share Units (“RSUs”)...

Reminder to register: Invitation to Multitude AG’s FY2025 Preliminary Results Presentation – Join us virtually on 12 March 2026 at 10 am CET

Written by Customer Service on March 2, 2026. Posted in Earnings Releases And Operating Results.

Zug, 02 March 2026 – Multitude AG, a listed European FinTech company, offering digital lending and online banking services to consumers, small and medium-sized enterprises, and other FinTechs (WKN: A40VJN, ISIN: CH1398992755) (“Multitude”, “Company” or “Group”) warmly invites financial analysts, investors, and media to its FY2025 Preliminary Results Presentation webcast. The event will be held virtually on Thursday, 12 March 2026, at 10:00 am CET. A link for registration to the webcast is available on the company website in the subsection financial calendar https://www.multitude.com/investors/financial-calendar. Contact:Multitude AG Grafenauweg 8 6300 Zug Switzerland Adam Hansson TönningHead of IR and TreasuryPhone: +46733583171ir@multitude.com About Multitude AG: Multitude is a listed European FinTech company, offering digital lending...

Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline

Written by Customer Service on March 2, 2026. Posted in Mergers And Acquisitions.

Acquisition will create a U.S.- and China-based fully integrated biopharmaceutical company with revenue-producing commercial assets and a robust pipeline of degraders, targeting inflammatory diseases and cancers. Access to degrader-antibody conjugates (DACs) platform technology for future discovery engine. Strengthened leadership team designed to support future global growth. Transaction is anticipated to close early in the second quarter of 2026. An updated corporate presentation has been posted to the Gyre and Cullgen websites.SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) — Gyre Therapeutics, Inc. (Gyre or the Company) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic diseases, today announced its agreement to acquire...

Bitcoin Depot Expands Product Portfolio with Acquisition of Social Betting Platform, Kutt

Written by Customer Service on March 2, 2026. Posted in Mergers And Acquisitions.

Company Enters Peer-to-Peer Social Betting Market as Part of Broader Product Diversification Strategy ATLANTA, March 02, 2026 (GLOBE NEWSWIRE) — Bitcoin Depot (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced that it has acquired Kutt, a peer-to-peer (“P2P”) social betting platform that enables users to wager directly against each other on both private and publicly verifiable events. The acquisition marks Bitcoin Depot’s first entry into the P2P social betting market and reflects the Company’s broader strategy to diversify its product offerings beyond its core Bitcoin ATM business. Kutt’s platform is positioned within one of the fastest-growing segments of consumer fintech, as Americans wagered over $165 billion through U.S. sportsbooks in 2025, reflecting the continued expansion...

UroGen Announces ZUSDURI™ Launch is On-Track and Reports Fourth Quarter and Full Year 2025 Financial Results

Written by Customer Service on March 2, 2026. Posted in Earnings Releases And Operating Results.

Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC); net sales in 2025 were $15.8 million, reflecting the initial launch period ahead of the permanent J Code Permanent J Code for ZUSDURI became effective on January 1, 2026, streamlining reimbursement procedures and supporting broader patient access JELMYTO® achieved net product sales of $94 million in 2025, representing year-over-year underlying demand sales growth of 7% Announced refinancing of existing term loan with Pharmakon Advisors that provides additional non-dilutive capital at more favorable terms Conference call and webcast to be held today at 10:00 AM ETPRINCETON, N.J., March 02, 2026 (GLOBE NEWSWIRE) — UroGen Pharma Ltd....

Uniti Group Inc. Reports Fourth Quarter and Full Year 2025 Results

Written by Customer Service on March 2, 2026. Posted in Earnings Releases And Operating Results.

Recently Completed Inaugural Kinetic ABS and Refinancing Activity Strengthens Uniti’s Balance Sheet at Attractive Cost of Capital Signed Largest Customer Contract in Uniti’s History with Prominent Hyperscaler Provides Full Year 2026 OutlookNet Loss of $305.7 Million for the Fourth Quarter and Net Income of $1,304.7 Million for the Full Year Consolidated Revenue and Adjusted EBITDA of $917.3 Million and $365.6 Million, Respectively, for the Fourth Quarter Consolidated Revenue and Adjusted EBITDA of $2,234.5 Million and $1,173.8 Million, Respectively, for the Full YearLITTLE ROCK, Ark., March 02, 2026 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti” or the “Company”) (Nasdaq: UNIT) today announced its results for the fourth quarter and full year 2025. Key highlights during the quarter on a pro forma basis included:Consolidated...

California Resources Corporation Reports Fourth Quarter and Full-Year 2025 Financial and Operating Results; Announces 2026 Guidance

Written by Customer Service on March 2, 2026. Posted in Earnings Releases And Operating Results.

25% Year-Over-Year Production Growth and Highest Annual Free Cash Flow Since 2021 Receipt of New Drilling Permits Supports Planned 2026 Drilling Program LONG BEACH, Calif., March 02, 2026 (GLOBE NEWSWIRE) — California Resources Corporation (NYSE: CRC) (CRC) today reported its financial and operating results for the fourth quarter and full-year 2025. The Company plans to host a conference call and webcast at 1 p.m. ET (10 a.m. PT) on Monday, March 2, 2026. Conference call details can be found within this release. Fourth Quarter HighlightsReported net income of $12 million, adjusted net income1 of $40 million and $251 million of adjusted EBITDAX1 Generated net cash provided by operating activities of $235 million and $115 million of free cash flow1 Delivered an average of 137 thousand barrels of oil equivalent per day5 (MBoe/d)...

Yukon Metals Appoints Jim Coates as Permanent Full-Time CEO

Written by Customer Service on March 2, 2026. Posted in Public Companies.

VANCOUVER, British Columbia, March 02, 2026 (GLOBE NEWSWIRE) — Yukon Metals Corp. (CSE: YMC, FSE: E770, OTCQB: YMMCF) (“Yukon Metals” or the “Company) is pleased to announce that Jim Coates, who has been serving as Interim CEO, has been appointed as the Company’s permanent full-time Chief Executive Officer, effective immediately. In his role, Mr. Coates will continue to lead the execution of Yukon Metals’ strategic exploration priorities, including executing drill programs at each of the Birch and AZ projects beginning in Q2, building upon the objectives advanced during his interim tenure. Jim Coates, CEO & Director stated: “I have worked closely with our team over the last two years, first as a Director, then Executive Vice President and more recently as Interim CEO, and have gained an understanding of the immense potential...

UroGen Announces Refinanced Term Loan Agreement with Pharmakon Advisors

Written by Customer Service on March 2, 2026. Posted in Public Companies.

Opportunistic refinancing meaningfully reduces cost of capital with 8.25% fixed interest rate and extends amortization period to Q1 2030 $200 million funded at closing to refinance the existing $125 million debt facility and provide additional non-dilutive capital Additional $50 million tranche available at Company’s discretion until June 30, 2027 PRINCETON, N.J., March 02, 2026 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, announced it has entered into an agreement with funds managed by Pharmakon Advisors, LP (Pharmakon) to revise the terms of its loan agreement entered into in March 2024. On February 26, 2026, the Company entered into an amended and restated loan agreement with funds managed by Pharmakon...

Day: March 2, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals